Proprotein Convertase Subtilisin/Kexin 9 as a Modifier of Lipid Metabolism in Atherosclerosis

Despite being the most common treatment strategy in the management of atherosclerosis and subsequent cardiovascular disease, classical statin therapy has certain disadvantages, including numerous side effects. In addition, a regimen with daily administration of the drug is hard to comply with. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Poznyak, Anastasia V., Sukhorukov, Vasily N., Eremin, Ilya I., Nadelyaeva, Irina I., Gutyrchik, Nikita A., Orekhov, Alexander N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953442/
https://www.ncbi.nlm.nih.gov/pubmed/36831039
http://dx.doi.org/10.3390/biomedicines11020503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953442/
https://www.ncbi.nlm.nih.gov/pubmed/36831039
http://dx.doi.org/10.3390/biomedicines11020503

Ejemplares similares